BCMA-targeted autologous CAR T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BCMA-targeted autologous CAR T cell therapy, covering 2025-05-21 to 2025-05-21. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Clinical Study on the Safety and Efficacy of Targeted BCMA Autologous CART Cell Injection in Subjects With Recurrent/Refractory Light Chain Amyloidosis [NA]